INKT · MiNK Therapeutics, Inc.
$11.64
+0.41 (+3.65%)
At close · Sep 4
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the completion of anticipated funding is not entirely within the Company's control, the Company is required to disclose that substantial doubt exists about its ability to continue as a going concern for a period of one year after the date of filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$59.40M
Shares
5.10M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-06-23 | 2026-06-17 | |
| 8-K | 2026-05-15 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | 2026-06-17 | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-27 | — | |
| 8-K | 2026-03-19 | 2026-03-13 | |
| 8-K | 2026-01-02 | 2025-12-29 | |
| 8-K | 2025-12-08 | 2025-11-14 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-09-29 | 2025-09-23 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-07-14 | 2025-07-11 | |
| 8-K | 2025-06-18 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| DEF 14A | 2025-04-30 | 2024-12-31 | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-01-21 | 2025-01-17 | |
| DEF 14A | 2024-12-20 | 2025-01-17 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-10-31 | 2024-10-30 | |
| 8-K | 2024-10-18 | 2024-10-15 | |
| 8-K | 2024-09-13 | — | |
| 8-K | 2024-08-30 | 2024-08-27 | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-17 | 2024-06-12 | |
| 8-K | 2024-05-16 | 2024-05-13 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | — | |
| DEF 14A | 2024-04-29 | 2023-12-31 | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-02-29 | 2024-02-23 | |
| 8-K | 2024-02-14 | 2024-02-12 | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-10-17 | 2023-10-12 | |
| 8-K | 2023-08-10 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-06-20 | 2023-06-13 | |
| 8-K | 2023-05-11 | — |
Showing 1–50 of 68 filings
Key facts
CIK
1840229
CUSIP
603693201
13F (30d)
18 filings
18 filers
Visit website
Investor relations